Michael A. Metzger - 10 Jun 2024 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Michael A. Metzger
Issuer symbol
PYXS
Transactions as of
10 Jun 2024
Net transactions value
$0
Form type
4
Filing time
10 Jun 2024, 17:31:39 UTC
Previous filing
09 Feb 2024
Next filing
07 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to Buy) Award $0 +70,683 $0.000000 70,683 10 Jun 2024 Common Stock 70,683 $3.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in three equal annual installments beginning on the first anniversary of June 10, 2024, subject to the reporting person's continued service through the applicable vesting date.